OncoCyte Balance Sheet Health
Financial Health criteria checks 3/6
OncoCyte has a total shareholder equity of $48.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $87.5M and $39.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$17.90m |
| Equity | US$48.33m |
| Total liabilities | US$39.22m |
| Total assets | US$87.54m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7OC0's short term assets ($21.0M) exceed its short term liabilities ($7.7M).
Long Term Liabilities: 7OC0's short term assets ($21.0M) do not cover its long term liabilities ($31.5M).
Debt to Equity History and Analysis
Debt Level: 7OC0 is debt free.
Reducing Debt: 7OC0 has no debt compared to 5 years ago when its debt to equity ratio was 22.1%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7OC0 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 7OC0 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.9% each year